Second-Line Irinotecan, Leucovorin, and 5-Fluorouracil for Gastric Cancer Patients after Failed Docetaxel and S-1

Table 3

Treatment-related adverse events.

	Grade 1		Grade 2		Grade 3
	Number	%	Number	%	Number	%
Haematological
Neutropenia	2	5.7	8	22.9	3	8.6
Anaemia	6	17.1	6	17.1	1	2.9
Thrombocytopenia	4	11.4	0	0	0	0
Febrile neutropenia	0	0	3	8.6	1	2.9
Nonhaematological
Anorexia	0	0	3	8.6	1	2.9
Emesis	2	5.7	3	8.6	0	0
Stomatitis	1	2.9	2	5.7	0	0
Diarrhoea	1	2.9	2	5.7	0	0
Neuropathy	2	5.7	0	0	0	0